The clinical features of squamous cell lung carcinoma with sensitive EGFR mutations

ConclusionThe administration of afatinib to Sq patients after selecting patients using the EGFR mutation test based on their underlying pulmonary disease and smoking status would likely result in a population with a greater sensitivity to afatinib.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research